PolyVascular, Inc.
PrivateLast Round
Grant
Oct 22, 2026
Total Funding Raised
$8.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PolyVascular, Inc. operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in October 2026.
PolyVascular, Inc. is a medical device company that develops minimally invasive, polymeric transcatheter heart valves for children with congenital heart disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PolyVascular, Inc. Comparables
Compare PolyVascular, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autus Valve Technologies, Inc. | 93% | |
| PECA Labs, Inc. | 87% | |
| Novostia | 80% |
For institutional investors. Book with your work email.
PolyVascular, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 22, 2026 | ||||
| Grant | Apr 24, 2025 | ||||
| Seed | Aug 29, 2023 | ||||
| Grant | Jul 12, 2023 | ||||
| Grant | Mar 30, 2021 | ||||
Accelerator | Jun 16, 2020 |
For institutional investors. Book with your work email.
PolyVascular, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CobiCure MedTech | Grant |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| SWPDC | Grant |
| Texas New Venture Competition | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2026
$15K grant received from Advanced Medical Technology Association and Medmarc.
- Aug 21, 2026
Monthly visitors grew 30% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 27, 2026
Polyvascular attends The MedTech Conference in Massachusetts on Oct 20th '26 and wins the 2026 AdvaMed Accel Virginia Shimer Rybski Memorial Award for its work on a transcatheter pulmonary valve for young children with congenital heart disease.
- receives_awardOct 27, 2026
Polyvascular receives the 2026 AdvaMed Accel Virginia Shimer Rybski Memorial Award from AdvaMed Accel at The MedTech Conference in Massachusetts on Oct 20th '26 for its work on a transcatheter pulmonary valve for young children with congenital heart disease.
For institutional investors. Book with your work email.
PolyVascular, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PolyVascular, Inc.'s valuation, stock price, and market status.
Is PolyVascular, Inc. a public or private company?
PolyVascular, Inc. is a private company.
What is the current stock price of PolyVascular, Inc.?
PolyVascular, Inc. is a private company, so its shares have no public market price. Caplight tracks PolyVascular, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PolyVascular, Inc. worth (valuation)?
Valuation information for PolyVascular, Inc. is not publicly available.
Can I buy PolyVascular, Inc. stock?
PolyVascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PolyVascular, Inc.'s last funding round?
PolyVascular, Inc.'s most recent funding round was Grant on October 22, 2026.
Who are the main investors in PolyVascular, Inc.?
Key investors in PolyVascular, Inc. include CobiCure MedTech, MedTech Innovator, NIH RADx, SWPDC, Texas New Venture Competition.
Will PolyVascular, Inc. IPO soon?
No public IPO plans have been announced for PolyVascular, Inc..
How can I track PolyVascular, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in PolyVascular, Inc.'s shares on secondary markets.